Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method - Wikidata - wikimedia - TriplyDB

Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method

Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method

http://www.wikidata.org/entity/Q34589262

about

Manufacturing of recombinant adeno-associated viral vectors for clinical trials Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency A review of augmentation therapy for alpha-1 antitrypsin deficiency.Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease.Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.Progress and challenges in viral vector manufacturing Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.Gene therapy for alpha-1 antitrypsin deficiency.The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Recent advances in α-1-antitrypsin deficiency-related lung disease.Current status of gene therapy for α-1 antitrypsin deficiency.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform.Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs.α1-Antitrypsin deficiency.Pharmacology of Recombinant Adeno-associated Virus Production.

P2860

Q26750799-F69AD2BE-EDC0-4FCF-B73F-F47D7F8C7A1E Q28080450-B6110EEF-47CC-4379-8103-75D5407EAFE3 Q28085148-005B76F1-D824-4860-96F4-84AEDFC2CC8A Q34268108-A7993BAB-CB34-4476-A677-12D6BDD37DD6 Q35063726-92F9D0C3-1C83-4027-9F3D-96028036D858 Q35184237-366B2CE8-198E-4053-8FA2-1E832CD7B337 Q35496285-9A43C303-E816-4A4C-9957-1E7F8B0588D7 Q36466909-CAC43E3C-150D-4A37-BAAC-B7BCDCC89DF6 Q36677162-E2DBBE05-3B1F-4F11-805D-215D20858FF0 Q36713761-3B721307-8A4B-4E70-A2DD-FEA640878B3B Q36852206-955CD610-96FB-4283-ACFA-8AAF411963B8 Q37134964-DE9BABA6-4F54-4F1F-94CE-0C0CC5B35072 Q37384103-B01FA02E-5125-4E0D-A891-B760B4847F6F Q37731874-EF366136-6D12-4944-BEE3-D20786C77F37 Q37866000-BA40C71C-B5A4-4EE6-9093-825B9134D962 Q37894093-A24B5FFE-B376-42BD-A7FB-72752FD04005 Q38111790-2DB0F68A-C8C8-4FD1-80FB-10F85CD66EA2 Q38264336-6D55E9D9-5CFD-4CAC-A039-B71533359A4C Q38937862-F5D28C5F-91CF-4974-AF13-4CFC5FD29637 Q39737661-095C8510-6542-463A-88E2-38EBC4A10412 Q45873049-623FEF01-EB42-47B0-B603-7BFB157EE24F Q51481224-3326427D-7FC2-4F42-AECB-4D9F8AA7220D Q52717185-C8A471E7-684C-4DA8-9AB1-392ECFD473AC

P2860

Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method

http://www.wikidata.org/entity/Q34589262

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Preclinical evaluation of a re ...... implex virus production method

@ast

Preclinical evaluation of a re ...... implex virus production method

@en

Preclinical evaluation of a re ...... implex virus production method

@nl

type

label

Preclinical evaluation of a re ...... implex virus production method

@ast

Preclinical evaluation of a re ...... implex virus production method

@en

Preclinical evaluation of a re ...... implex virus production method

@nl

prefLabel

Preclinical evaluation of a re ...... implex virus production method

@ast

Preclinical evaluation of a re ...... implex virus production method

@en

Preclinical evaluation of a re ...... implex virus production method

@nl

P1433

Q34589262-98BAB104-98D7-4DC5-AB55-568FD7E45106

P1476

Q34589262-34233A84-B647-42F1-87EC-F1ED91505A9D

P2093

Q34589262-3EBA7C74-F303-4E9C-9C85-F2C51973A197

Q34589262-43EF1B4C-4B6F-43EB-BC24-BF369D9C8928

Q34589262-50FBF445-0DC7-4AC4-A5FA-F9856C87D90C

Q34589262-7EED2643-698F-4A2E-BC66-FADDF9A65AF4

Q34589262-BB05867D-331E-400F-B02B-48A7910DFA70

Q34589262-C23A405A-67CC-4CCC-8DEA-930208299241

Q34589262-C2D1F042-743B-4C56-88A3-EA6A49516A16

Q34589262-D49FC384-FECA-4365-83BE-5A6E1ED3B84D

Q34589262-E1AEF16C-AE91-4BEA-9701-CAE0D70A0F5F

P2860

Q34589262-06F04A05-BE00-454F-8EBD-280A935D898C

Q34589262-0C739930-78F5-44B1-A8CF-9B0F126ED806

Q34589262-2011340E-F84B-4C1E-8C60-1E7BCF07786F

Q34589262-2B663C4B-1697-4F04-9FB6-E8A8A4613149

Q34589262-3480298A-C3A5-4D55-A10B-A7FCF8370E35

Q34589262-3D97ADD2-7319-4168-8545-43570AE157A7

Q34589262-45BBE4A2-2C43-4FFF-AF9A-7CAF14E67B48

Q34589262-4F1C2075-338A-44DE-8ADB-275214D1D04E

Q34589262-56F73665-BA5E-4C54-88A8-8056C4E8F8E1

Q34589262-64E8D5D8-B31D-4B11-A3ED-0BEC4FA69708

P304

Q34589262-71E07AE2-0E65-464D-B3BA-A013C36B6961

P31

Q34589262-8C4B2B22-C493-4004-8369-E0D377B3AE55

P356

Q34589262-2E98DD31-CC92-4E63-8498-A3398634906E

P433

Q34589262-EEFCCB22-1FF7-40AD-801A-20B17CC690BB

P478

Q34589262-47FE33F2-9169-4064-A4A9-121847D4BF21

P577

Q34589262-027100BC-3072-4498-B81F-614658B5E402

P5875

Q34589262-F8960F1C-B570-403D-B843-EFFC5CB4AD0A

P698

Q34589262-D88B4A96-752A-4ED1-B6C8-9EA6982CAC1E

P921

Q34589262-4704A8B4-C9DE-4B9C-929E-982CD38E8CAA

P932

Q34589262-083B6D00-A02E-4659-8579-328FCB3063CD

P356

P1433

Human Gene Therapy

P1476

Preclinical evaluation of a re ...... implex virus production method

@en

P2093

Darby L Thomas

http://www.w3.org/2001/XMLSchema#string

David R Knop

http://www.w3.org/2001/XMLSchema#string

Gensheng Wang

http://www.w3.org/2001/XMLSchema#string

Guo-Jie Ye

http://www.w3.org/2001/XMLSchema#string

Janet M Benson

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Chulay

http://www.w3.org/2001/XMLSchema#string

Julie A Hutt

http://www.w3.org/2001/XMLSchema#string

Margaret Humphries

http://www.w3.org/2001/XMLSchema#string

Terence R Flotte

http://www.w3.org/2001/XMLSchema#string

P2860

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Approximate variance-stabilizing transformations for gene-expression microarray data.

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Clinical practice. Alpha1-antitrypsin deficiency.

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.

Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery

P304

155-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2010.118

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46123336

http://www.w3.org/2001/XMLSchema#string

P698

20812844

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

3042310

http://www.w3.org/2001/XMLSchema#string